Recommended Approach for Diagnosing Lymphoma
The gold standard for diagnosing lymphoma is an excisional or incisional lymph node biopsy, as fine-needle aspiration is inadequate for initial diagnosis. 1, 2
Initial Diagnostic Evaluation
- Diagnosis should always be based on a surgical specimen/excisional lymph node biopsy providing adequate tissue for morphology, immunohistochemistry, flow cytometry, and molecular studies 1, 2
- Core needle biopsies should only be performed when excisional biopsy is not possible (e.g., retroperitoneal nodes) or to document relapse 1, 2
- Fine-needle aspirations are inappropriate for reliable diagnosis and should be avoided 1, 2
- When possible, additional tissue should be stored fresh frozen to allow for future molecular analyses 1
- The histological report should follow the World Health Organization classification 1, 2
Clinical Evaluation
Comprehensive history should document:
Physical examination should include:
Laboratory Studies
- Complete blood count with differential 1, 2, 3
- Comprehensive chemistry panel including:
- Mandatory screening for HIV, hepatitis B, and hepatitis C 1, 2, 3
- Protein electrophoresis (recommended for B-cell lymphomas) 1
Imaging Studies
- PET-CT is the standard for FDG-avid lymphomas (Hodgkin lymphoma, aggressive NHL, many indolent NHLs) 1, 2, 4
- CT scan of neck, chest, abdomen, and pelvis with contrast is required if PET-CT is not available 1, 2, 4
- PET-CT improves staging accuracy compared to CT alone, particularly important before radiation therapy 1
Bone Marrow Assessment
- Bone marrow aspirate and biopsy should be performed 1
- PET-CT may be adequate for determining bone marrow involvement in Hodgkin lymphoma, but biopsy confirmation may still be needed for other lymphoma types 1, 2, 4
Additional Evaluations for Specific Presentations
- For suspected CNS involvement:
- For suspected gastrointestinal involvement:
- Endoscopy with biopsy 2
Staging and Risk Assessment
- Staging should follow the Ann Arbor/Lugano classification system 1, 2
- For prognostic purposes, the International Prognostic Index (IPI) should be established for aggressive lymphomas 1
- For follicular lymphoma, the Follicular Lymphoma International Prognostic Index (FLIPI) should be determined 1, 2
Common Pitfalls to Avoid
- Relying on fine-needle aspiration for initial diagnosis (inadequate tissue) 1, 2
- Performing core biopsies when excisional biopsies are feasible 1
- Failing to store additional tissue for molecular studies 1
- Initiating treatment before complete staging evaluation 1, 2
- Overlooking the need for hepatitis and HIV screening which can impact treatment decisions 1, 3
By following this systematic approach to lymphoma diagnosis, clinicians can ensure accurate classification and staging, which are essential for determining appropriate treatment strategies and improving patient outcomes.